Talking Points and FAQs: What You Need to Know About Novavax's Updated COVID-19 Vaccine (English, Spanish)
Talking Points and FAQs: What You Need to Know About Novavax's Updated COVID-19 Vaccine (English, Spanish)
Date posted:
October 19, 2023
Last reviewed:
October 19, 2023
The Public Good Projects, Hispanic Communications Network
Talking points and FAQs cover how Novavax’s updated COVID-19 vaccine is different from Pfizer’s and Moderna’s vaccines and highlight that all three are safe and effective at protecting us against COVID-19. The talking points discuss who is eligible for Novavax vaccines and the recommended number of doses based on prior vaccination history. A related graphic is available here: Social Media: Graphic Explains What to Know About Novavax's Updated COVID-19 Vaccine (English, Spanish).
Download Resource
Factsheet: Influenza FAQ (English, 33 Other Languages)
Matching terms:
Branded
Video: Sharing Trusted Information About COVID-19 Vaccines on Social Media – Share Button (English, Spanish) (0:16)
Matching terms:
Social Media COVID-19 Branded
Tool: Form for Employees to Sign When They Decline an Influenza Vaccine
Matching terms:
Branded Document (Text)
Social Media: Graphic Encourages Getting the Flu Shot Before Halloween (English, Spanish)
Matching terms:
Social Media Unbranded Graphic / Image
Report: Analysis of COVID-19 Vaccination and Clinical Outcomes with Patients' Preferred Language
Matching terms:
Branded Website
Talking Points and FAQs: Routine Vaccines Keep Kids Safe (English, Spanish)
Matching terms:
COVID-19 Flu/Influenza Branded